MHC Universal Cells Survive in an Allogeneic Environment after Incompatible Transplantation
Open Access
- 1 January 2013
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2013, 1-12
Abstract
Cell, tissue, and organ transplants are commonly performed for the treatment of different diseases. However, major histocompatibility complex (MHC) diversity often prevents complete donor-recipient matching, resulting in graft rejection. This study evaluates in a preclinical model the capacity of MHC class I-silenced cells to engraft and grow upon allogeneic transplantation. Short hairpin RNA targetingβ2-microglobulin (RN_shβ2m) was delivered into fibroblasts derived from LEW/Ztm () (RT1-) rats using a lentiviral-based vector. MHC class I (RT1-A-) expressing and -silenced cells were injected subcutaneously in LEW rats () and MHC-congenic LEW.1W rats (), respectively. Cell engraftment and the status of the immune response were monitored for eight weeks after transplantation. In contrast to RT1-A-expressing cells, RT1-A-silenced fibroblasts became engrafted and were still detectable eight weeks after allogeneic transplantation. Plasma levels of proinflammatory cytokines IL-1α, IL-1β, IL-6, TNF-α, and IFN-γwere significantly higher in animals transplanted with RT1-A-expressing cells than in those receiving RT1-A-silenced cells. Furthermore, alloantigen-specific T-cell proliferation rates derived from rats receiving RT1-A-expressing cells were higher than those in rats transplanted with RT1-A-silenced cells. These data suggest that silencing MHC class I expression might overcome the histocompatibility barrier, potentially opening up new avenues in the field of cell transplantation and regenerative medicine.
Keywords
Funding Information
- German Research Foundation (REBIRTH, EXC 62)
This publication has 45 references indexed in Scilit:
- Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantationBlood, 2013
- RNAi-mediated knockdown of relaxin decreases in vitro proliferation and invasiveness of osteosarcoma MG-63 cells by inhibition of MMP-9.2013
- PLGA microspheres encapsulating siRNA anti-TNFalpha: Efficient RNAi-mediated treatment of arthritic jointsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2012
- Predicting HLA Class I Non-Permissive Amino Acid Residues SubstitutionsPLOS ONE, 2012
- Human Leukocyte Antigen Antibody-Incompatible Renal Transplantation: Excellent Medium-Term Outcomes With Negative Cytotoxic CrossmatchTransplantation, 2011
- Current prospects for RNA interference-based therapiesNature Reviews Genetics, 2011
- Commercialization Challenges Associated with Induced Pluripotent Stem Cell-Based ProductsRegenerative Medicine, 2010
- Differential Modeling of Fragile X Syndrome by Human Embryonic Stem Cells and Induced Pluripotent Stem CellsCell Stem Cell, 2010
- Down-regulation of inducible co-stimulator (ICOS) by intravitreal injection of small interfering RNA (siRNA) plasmid suppresses ongoing experimental autoimmune uveoretinitis in ratsGraefe's Archive for Clinical and Experimental Ophthalmology, 2009
- Genomic and funtional aspects of the rat MHC, the RT1 complexImmunological Reviews, 2001